175 related articles for article (PubMed ID: 25324198)
1. Optimal colorectal cancer screening in states' low-income, uninsured populations—the case of South Carolina.
van der Steen A; Knudsen AB; van Hees F; Walter GP; Berger FG; Daguise VG; Kuntz KM; Zauber AG; van Ballegooijen M; Lansdorp-Vogelaar I
Health Serv Res; 2015 Jun; 50(3):768-89. PubMed ID: 25324198
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
3. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
[TBL] [Abstract][Full Text] [Related]
4. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
5. Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.
Gini A; Zauber AG; Cenin DR; Omidvari AH; Hempstead SE; Fink AK; Lowenfels AB; Lansdorp-Vogelaar I
Gastroenterology; 2018 Feb; 154(3):556-567.e18. PubMed ID: 29102616
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People.
Redwood DG; Dinh TA; Kisiel JB; Borah BJ; Moriarty JP; Provost EM; Sacco FD; Tiesinga JJ; Ahlquist DA
Mayo Clin Proc; 2021 May; 96(5):1203-1217. PubMed ID: 33840520
[TBL] [Abstract][Full Text] [Related]
7. Colon cancer screening for Colorado's underserved: a community clinic/academic partnership.
Wolf HJ; Dwyer A; Ahnen DJ; Pray SL; Rein SM; Morwood KD; Lowery JT; Masias A; Collins NJ; Brown CE; DeMaio Goheen CA; McAbee KE; Sauaia A; Byers TE
Am J Prev Med; 2015 Mar; 48(3):264-70. PubMed ID: 25547926
[TBL] [Abstract][Full Text] [Related]
8. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
[TBL] [Abstract][Full Text] [Related]
9. Fecal-based colorectal cancer screening among the uninsured in northern Manhattan.
Hillyer GC; Schmitt KM; Freedberg DE; Kramer RA; Su Y; Rosenberg RM; Neugut AI
Am J Prev Med; 2014 Aug; 47(2):182-7. PubMed ID: 24951037
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
11. Rescreening of persons with a negative colonoscopy result: results from a microsimulation model.
Knudsen AB; Hur C; Gazelle GS; Schrag D; McFarland EG; Kuntz KM
Ann Intern Med; 2012 Nov; 157(9):611-20. PubMed ID: 23128861
[TBL] [Abstract][Full Text] [Related]
12. Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline.
Meester RGS; Peterse EFP; Knudsen AB; de Weerdt AC; Chen JC; Lietz AP; Dwyer A; Ahnen DJ; Siegel RL; Smith RA; Zauber AG; Lansdorp-Vogelaar I
Cancer; 2018 Jul; 124(14):2974-2985. PubMed ID: 29846942
[TBL] [Abstract][Full Text] [Related]
13. A statewide program providing colorectal cancer screening to the uninsured of South Carolina.
Eberth JM; Thibault A; Caldwell R; Josey MJ; Qiang B; Peña E; LaFrance D; Berger FG
Cancer; 2018 May; 124(9):1912-1920. PubMed ID: 29415338
[TBL] [Abstract][Full Text] [Related]
14. Determinants of variations in self-reported barriers to colonoscopy among uninsured patients in a primary care setting.
Ojinnaka C; Vuong A; Helduser J; Nash P; Ory MG; McClellan DA; Bolin JN
J Community Health; 2015 Apr; 40(2):260-70. PubMed ID: 25096763
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals.
Ladabaum U; Mannalithara A; Jandorf L; Itzkowitz SH
Cancer; 2015 Apr; 121(7):1088-97. PubMed ID: 25492455
[TBL] [Abstract][Full Text] [Related]
16. Would initiating colorectal cancer screening from age of 45 be cost-effective in Germany? An individual-level simulation analysis.
Lwin MW; Cheng CY; Calderazzo S; Schramm C; Schlander M
Front Public Health; 2024; 12():1307427. PubMed ID: 38454984
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of screening for colorectal cancer in the general population.
Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
Ladabaum U; Mannalithara A
Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
[TBL] [Abstract][Full Text] [Related]
19. Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests.
Peterse EFP; Meester RGS; de Jonge L; Omidvari AH; Alarid-Escudero F; Knudsen AB; Zauber AG; Lansdorp-Vogelaar I
J Natl Cancer Inst; 2021 Feb; 113(2):154-161. PubMed ID: 32761199
[TBL] [Abstract][Full Text] [Related]
20. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
